FABPs: Novel Roles in Pain and Inflammation
FABP:在疼痛和炎症中的新作用
基本信息
- 批准号:8874187
- 负责人:
- 金额:$ 34.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:2-arachidonylglycerolAblationAbsence of pain sensationAccountingAcute inflammatory painAdverse effectsAfferent NeuronsAnalgesicsAnti-Inflammatory AgentsAnti-inflammatoryBehaviorBrainCatabolismCell membraneCultured CellsDependencyDevelopmentDrug TargetingEndocannabinoidsEnzymesFoundationsFutureGeneticGoalsHealthIn VitroIndividualInflammationInflammation MediatorsInflammatoryKnockout MiceKnowledgeLeadLipidsMass Spectrum AnalysisMeasuresMediatingMedicalModelingMorphineMusMutant Strains MiceNervous system structureNeuronsNociceptionNociceptorsOutputOxycodonePPAR alphaPainPeripheralPeripheral NervesPopulationProductivityProstaglandin ProductionProstaglandinsProtein InhibitionProteinsRiskRoleSignal TransductionSiteSpinal CordTestingTimeTissuesTransgenic OrganismsWild Type MouseWorkaddictionanandamidebasecannabinoid receptorchronic paincytokinedrug developmentfatty acid amide hydrolasefatty acid-binding proteinsimprovedin vivoinflammatory paininhibitor/antagonistnoveloleoylethanolamidepalmidrolpreclinical studyreceptortherapeutic targettreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Chronic pain accounts for billions of dollars of lost productivity and medical expenses annually. Current treatment strategies suffer from partial efficacy across the population, resulting in inadequate pain relief. Furthermore, many chronically administered analgesics (e.g., morphine or oxycontin), while actually effective, lead to tolerance and addiction. Consequently, it is imperative to identify novel drug targets for the development of non-addictive analgesics. Bioactive lipids such as endocannabinoids and N-acylethanolamines (NAEs) regulate nociception throughout the nervous system. Preclinical studies suggest that modulation of endocannabinoid and NAE catabolism represents an attractive strategy for the treatment of pain that is also devoid of psychotropic effects. Recently we identified fatty acid binding proteins (FABPs) as the first intracellular carriers that regulate
endocannabinoid and NAE transport and inactivation in vitro. To date, it is not known whether FABPs regulate the endocannabinoid and NAE tone in vivo. The central goals of this project are to determine whether FABPs regulate endocannabinoid and NAE signaling and inactivation in vivo and to ascertain whether inhibition of FABPs produces endocannabinoid- and NAE-mediated antinociception. We will accomplish this by first determining whether ablation of FABPs reduces nociception in models of inflammatory pain. We will then identify the FABP subtypes that modulate pain and inflammation through a combination of complementary approaches: pharmacological manipulation and transgenic FABP knockout mice lacking specific subsets of FABPs. In the second aim of this proposal, we will employ mass spectrometry-based lipidomics to determine whether FABPs regulate endocannabinoid and NAE levels in vivo at relevant anatomical sites and consequently whether FABP inhibition produces endocannabinoid- and NAE-mediated analgesia. Finally, in the last aim, we will examine changes in peripheral cytokine and prostaglandin levels that accompany FABP inhibition and determine whether FABP inhibition alters the sensitization of nociceptive neurons. In summary, this study will identify FABPs as novel proteins that regulate nociception and inflammation and will evaluate the roles for individual FABPs in endocannabinoid and NAE inactivation in vivo. By ascribing novel roles to FABPs in nociception, this work will provide a foundation for the development of future FABP targeting therapeutics that may lead to improved analgesics.
描述(由申请人提供):慢性疼痛每年造成数十亿美元的生产力损失和医疗费用。目前的治疗策略在整个人群中存在部分疗效,导致疼痛缓解不足。此外,许多长期施用的镇痛剂(例如,吗啡或奥施康定),虽然实际上有效,但会导致耐受和成瘾。因此,确定新的药物靶点以开发非成瘾性镇痛药势在必行。生物活性脂质如内源性大麻素和N-酰基乙醇胺(NAE)调节整个神经系统的伤害感受。临床前研究表明,调节内源性大麻素和NAE catalysts代表了一种有吸引力的治疗疼痛的策略,也没有精神作用。最近,我们确定了脂肪酸结合蛋白(FABPs)作为第一个细胞内载体,
内源性大麻素和NAE的转运和失活。迄今为止,尚不清楚FABP是否在体内调节内源性大麻素和NAE张力。 该项目的中心目标是确定FABPs是否在体内调节内源性大麻素和NAE信号传导和失活,并确定抑制FABPs是否产生内源性大麻素和NAE介导的抗伤害感受。我们将通过首先确定消融FABP是否减少炎性疼痛模型中的伤害感受来实现这一点。然后,我们将确定FABP亚型,调节疼痛和炎症,通过互补的方法相结合:药理学操作和转基因FABP敲除小鼠缺乏特定的FABP子集。在本提案的第二个目标中,我们将采用基于质谱的脂质组学来确定FABP是否在相关解剖部位调节体内内源性大麻素和NAE水平,从而确定FABP抑制是否产生内源性大麻素和NAE介导的镇痛作用。最后,在最后一个目标中,我们将检查伴随FABP抑制的外周细胞因子和前列腺素水平的变化,并确定FABP抑制是否改变伤害性神经元的敏化。总之,本研究将确定FABP作为调节伤害感受和炎症的新型蛋白质,并将评估个体FABP在体内内源性大麻素和NAE失活中的作用。通过将新的作用归因于FABP在伤害感受中,这项工作将为未来FABP靶向治疗的发展提供基础,从而可能导致改善镇痛剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Kaczocha其他文献
Martin Kaczocha的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Kaczocha', 18)}}的其他基金
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
开发下一代治疗前列腺癌的 FABP5 抑制剂
- 批准号:
10092979 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
开发下一代治疗前列腺癌的 FABP5 抑制剂
- 批准号:
10333221 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
开发下一代治疗前列腺癌的 FABP5 抑制剂
- 批准号:
10548832 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
开发下一代治疗前列腺癌的 FABP5 抑制剂
- 批准号:
9887053 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
相似海外基金
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 34.8万 - 项目类别:
Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 34.8万 - 项目类别:
Standard Grant
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 34.8万 - 项目类别:
Standard Grant